1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one has been researched along with Disbacteriosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hajishengallis, E; Hajishengallis, G; Hasturk, H; Kajikawa, T; Lambris, JD; Maekawa, T; Mastellos, DC; Reis, ES; Yancopoulou, D | 1 |
| Abe, T; Hajishengallis, E; Hajishengallis, G; Lambris, JD; Maekawa, T | 1 |
| Hajishengallis, E; Hajishengallis, G; Kajikawa, T; Lambris, JD; Ricklin, D; Wang, B; Yancopoulou, D | 1 |
3 review(s) available for 1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one and Disbacteriosis
| Article | Year |
|---|---|
Complement-Dependent Mechanisms and Interventions in Periodontal Disease.
Topics: Animals; Complement Activation; Complement C3; Dysbiosis; Humans; Macaca fascicularis; Mice; Periodontitis; Pyridones | 2019 |
Complement Involvement in Periodontitis: Molecular Mechanisms and Rational Therapeutic Approaches.
Topics: Animals; Bacteroidaceae Infections; Complement Activation; Complement Inactivating Agents; Complement System Proteins; Disease Models, Animal; Dysbiosis; Host-Pathogen Interactions; Humans; Macaca fascicularis; Mice; Peptides, Cyclic; Periodontitis; Porphyromonas gingivalis; Pyridones; Receptors, Complement | 2015 |
Complement inhibition in pre-clinical models of periodontitis and prospects for clinical application.
Topics: Animals; Complement C3; Complement C5; Complement Inactivating Agents; Drug Evaluation, Preclinical; Dysbiosis; Humans; Mouth; Periodontitis; Primates; Pyridones; Receptor, Anaphylatoxin C5a | 2016 |